- Home
- TTP vs DERM Comparison
TTP vs DERM Comparison
Compare TTP & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTP
- DERM
- Stock Information
- Founded
- TTP 2011
- DERM 2014
- Country
- TTP United States
- DERM United States
- Employees
- TTP N/A
- DERM N/A
- Industry
- TTP Trusts Except Educational Religious and Charitable
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- TTP Finance
- DERM Health Care
- Exchange
- TTP Nasdaq
- DERM Nasdaq
- Market Cap
- TTP 97.3M
- DERM 107.0M
- IPO Year
- TTP N/A
- DERM 2021
- Fundamental
- Price
- TTP $51.94
- DERM $5.20
- Analyst Decision
- TTP
- DERM Strong Buy
- Analyst Count
- TTP 0
- DERM 3
- Target Price
- TTP N/A
- DERM $9.50
- AVG Volume (30 Days)
- TTP 8.4K
- DERM 145.7K
- Earning Date
- TTP 01-01-0001
- DERM 11-12-2024
- Dividend Yield
- TTP 7.61%
- DERM N/A
- EPS Growth
- TTP N/A
- DERM N/A
- EPS
- TTP N/A
- DERM N/A
- Revenue
- TTP N/A
- DERM $57,771,000.00
- Revenue This Year
- TTP N/A
- DERM N/A
- Revenue Next Year
- TTP N/A
- DERM $37.38
- P/E Ratio
- TTP N/A
- DERM N/A
- Revenue Growth
- TTP N/A
- DERM N/A
- 52 Week Low
- TTP $24.75
- DERM $2.85
- 52 Week High
- TTP $31.22
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- TTP 87.77
- DERM 43.96
- Support Level
- TTP $49.00
- DERM $5.00
- Resistance Level
- TTP $50.78
- DERM $5.60
- Average True Range (ATR)
- TTP 1.18
- DERM 0.45
- MACD
- TTP 0.36
- DERM -0.04
- Stochastic Oscillator
- TTP 98.78
- DERM 14.98
About TTP Tortoise Pipeline & Energy Fund Inc.
Tortoise Pipeline & Energy Fund Inc is a non-diversified, closed-end investment management company. It invests in equity securities of North American pipeline companies that transport natural gas, natural gas liquids, crude oil, and refined products. The company seeks to invest in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.